先声药业集团有限公司（股票代码：02096）于2026年10月26日发布公告，当日通过香港联合交易所场内回购普通股约110.20万股，占已发行股本约0.043%。本次回购价格每股介乎港币10.49元至港币10.64元，总涉资约港币1,167.05万元。由于回购股份尚未注销，公司已发行股本仍为2,568,198,618股，且库藏股数为0。
公告显示，本次回购基于2026年6月12日通过的购回授权。公司可依据该授权回购股份的总数为256,819,861股，截至目前已累计在香港联交所或其他证券交易所回购10,787,000股，占授权通过当日已发行股份总数的4.2%。公司确认，本次回购事项已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由其联席公司秘书朱达签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.